Insmed (INSM) News Today $72.67 -1.05 (-1.42%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Insmed Incorporated (NASDAQ:INSM) Stock Holdings Lifted by Jennison Associates LLCJennison Associates LLC lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 769,253 shares of the biopharmaceNovember 21 at 5:32 AM | marketbeat.comInsmed: PAH Treatment Advancement With 2nd Half 2025Â Top-Line DataNovember 20 at 3:11 PM | seekingalpha.comInsmed's Options: A Look at What the Big Money is ThinkingNovember 19 at 4:46 PM | benzinga.comInsmed (NASDAQ:INSM) Shares Gap Up - Here's WhyInsmed (NASDAQ:INSM) Shares Gap Up - Time to Buy?November 19 at 1:34 PM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is First Turn Management LLC's 3rd Largest PositionFirst Turn Management LLC raised its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 356,451 shares of the biopharmaceutical company's stoNovember 19 at 6:15 AM | marketbeat.comOppenheimer Asset Management Inc. Grows Stake in Insmed Incorporated (NASDAQ:INSM)Oppenheimer Asset Management Inc. raised its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 115.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,449 shares of the biopNovember 19 at 3:58 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Receives Consensus Rating of "Buy" from BrokeragesShares of Insmed Incorporated (NASDAQ:INSM - Get Free Report) have been assigned an average rating of "Buy" from the sixteen analysts that are covering the company, MarketBeat reports. Sixteen analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokNovember 18 at 1:49 AM | marketbeat.comVictory Capital Management Inc. Buys 308,819 Shares of Insmed Incorporated (NASDAQ:INSM)Victory Capital Management Inc. lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 209.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 455,959 shares of the biopharmaceutical company's stock after acquiring an additional 308,81November 17, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Stake Lifted by WCM Investment Management LLCWCM Investment Management LLC grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 58.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 148,330 shares of the biopharmaceutNovember 12, 2024 | marketbeat.comOptimistic Buy Rating for Insmed Driven by Brensocatib Growth Potential and Strong Financial PositionNovember 11, 2024 | markets.businessinsider.comTimesSquare Capital Management LLC Purchases Shares of 483,869 Insmed Incorporated (NASDAQ:INSM)TimesSquare Capital Management LLC purchased a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 483,869 shares of the biopharmaceuticalNovember 10, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $136.65 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Principal Financial Group Inc. lifted its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.9% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,871,890 shares of the biopharmaceutical company's stock after buyiNovember 9, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Position Cut by Fiera Capital CorpFiera Capital Corp lowered its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 592,415 shares of the biopharmaceutical company's stock after selling 13,112 shares during the periodNovember 8, 2024 | marketbeat.comInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)November 7, 2024 | prnewswire.comVan ECK Associates Corp Acquires Shares of 127,024 Insmed Incorporated (NASDAQ:INSM)Van ECK Associates Corp bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 127,024 shares of the biopharmaceutical cNovember 7, 2024 | marketbeat.comInsmed To Present at November 2024 Investor ConferencesNovember 6, 2024 | prnewswire.comHarbor Capital Advisors Inc. Invests $1.29 Million in Insmed Incorporated (NASDAQ:INSM)Harbor Capital Advisors Inc. acquired a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 17,682 shares of the biopharmaceuticalNovember 6, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund trimmed its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 292,779 shares of the biopharmacNovember 5, 2024 | marketbeat.comPromising Outlook for Insmed: Brensocatib’s Novel Approach to CRSsNP and Expanding PipelineNovember 3, 2024 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) Shares Bought by Emerald Advisers LLCEmerald Advisers LLC grew its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 689,807 shares of the biopharmaceutical company's stock after acquiring an additional 49,540 shNovember 3, 2024 | marketbeat.comInsmed’s Strong Revenue Growth and Promising Pipeline Drive Buy RatingNovember 2, 2024 | markets.businessinsider.comDo You Believe in the Growth Potential of Insmed (INSM)?November 2, 2024 | msn.comInsmed’s Promising Pipeline and Strategic Readiness Drive Buy RatingNovember 2, 2024 | markets.businessinsider.comInsmed (NASDAQ:INSM) Issues Quarterly Earnings ResultsInsmed (NASDAQ:INSM - Get Free Report) announced its earnings results on Thursday. The biopharmaceutical company reported ($1.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.19) by ($0.08). The firm had revenue of $93.40 million during the quarter, compared to analysts' expectations of $93.36 million. During the same period in the prior year, the company earned ($1.10) earnings per share. The business's quarterly revenue was up 18.1% on a year-over-year basis.November 1, 2024 | marketbeat.comTruist Financial Reaffirms Buy Rating for Insmed (NASDAQ:INSM)Truist Financial reaffirmed a "buy" rating and issued a $105.00 price target (up previously from $100.00) on shares of Insmed in a report on Friday.November 1, 2024 | marketbeat.comQ3 2024 Insmed Inc Earnings CallNovember 1, 2024 | finance.yahoo.comInsmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...November 1, 2024 | finance.yahoo.comInsmed Reports Third-Quarter 2024 Financial Results and Provides Business UpdateOctober 31, 2024 | prnewswire.comA Glimpse of Insmed's Earnings PotentialOctober 31, 2024 | benzinga.comInsmed Q3 2024 Earnings PreviewOctober 31, 2024 | msn.comChina Universal Asset Management Co. Ltd. Purchases 14,110 Shares of Insmed Incorporated (NASDAQ:INSM)China Universal Asset Management Co. Ltd. lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 74.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,052 shares of the biopharmaceuticOctober 29, 2024 | marketbeat.comNovo Holdings A S Lowers Holdings in Insmed Incorporated (NASDAQ:INSM)Novo Holdings A S lessened its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 724,666 shares of the biopharmaceutical company's stock after selling 75,334 shares during the quarter. Insmed accountOctober 27, 2024 | marketbeat.comCreative Planning Increases Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Creative Planning raised its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 31.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,914 shares of the biopharmaceutical company's stoOctober 26, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $62.59 Million Stock Position in Insmed Incorporated (NASDAQ:INSM)Assenagon Asset Management S.A. boosted its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 119.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 857,360 shares of the biopharmaceutical company's stock afterOctober 25, 2024 | marketbeat.comInsmed Ranks No. 1 on Science's 2024 Top Biopharma Employers ListOctober 24, 2024 | prnewswire.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. decreased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 23.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 87,456 shares of the biopharmaceutical company's stock after selling 27,1October 24, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Given Average Recommendation of "Buy" by BrokeragesShares of Insmed Incorporated (NASDAQ:INSM - Get Free Report) have been given an average rating of "Buy" by the sixteen analysts that are presently covering the company, Marketbeat reports. Sixteen equities research analysts have rated the stock with a buy rating. The average 1 year price objectivOctober 24, 2024 | marketbeat.comInsmed (INSM) Scheduled to Post Quarterly Earnings on ThursdayInsmed (NASDAQ:INSM) will be releasing earnings before the market opens on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636691)October 24, 2024 | marketbeat.comInsmed Unites Across Communities Around the World During Third Annual Global Day of GoodOctober 23, 2024 | prnewswire.comInsmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024October 17, 2024 | prnewswire.comShort Interest in Insmed Incorporated (NASDAQ:INSM) Increases By 8.0%Insmed Incorporated (NASDAQ:INSM - Get Free Report) was the target of a large increase in short interest in September. As of September 30th, there was short interest totalling 13,200,000 shares, an increase of 8.0% from the September 15th total of 12,220,000 shares. Based on an average daily trading volume, of 1,970,000 shares, the short-interest ratio is presently 6.7 days.October 16, 2024 | marketbeat.comDimensional Fund Advisors LP Takes Position in Insmed Incorporated (NASDAQ:INSM)Dimensional Fund Advisors LP bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 12,089 shares of the biopharmaceutical company's stock, valued at approximately $810,000. SOctober 14, 2024 | marketbeat.comEssex Investment Management Co. LLC Has $5.64 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Essex Investment Management Co. LLC lowered its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 25.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,193 shares of the biopharmaceutical companyOctober 13, 2024 | marketbeat.comTruist Financial Increases Insmed (NASDAQ:INSM) Price Target to $100.00Truist Financial increased their target price on shares of Insmed from $85.00 to $100.00 and gave the company a "buy" rating in a research report on Friday.October 11, 2024 | marketbeat.comBarclays Sticks to Its Buy Rating for Insmed (INSM)October 10, 2024 | markets.businessinsider.comInsmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...October 10, 2024 | finance.yahoo.comBuy Rating Reaffirmed for Insmed as Brensocatib Shows Broad Positive Impact in Phase 3 StudyOctober 10, 2024 | markets.businessinsider.comBank of America Raises Insmed (NASDAQ:INSM) Price Target to $86.00Bank of America lifted their price target on Insmed from $84.00 to $86.00 and gave the stock a "buy" rating in a report on Wednesday.October 9, 2024 | marketbeat.comInsmed : Phase 3 Analyses Of Brensocatib In Bronchiectasis Align With Positive Overall Trial ResultsOctober 9, 2024 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) Stock Holdings Increased by Handelsbanken Fonder ABHandelsbanken Fonder AB grew its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 25.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 43,581 shares of the biopharmaceutical compaOctober 9, 2024 | marketbeat.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼0.900.45▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼77▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTC Therapeutics News Today Schrödinger News Today Emergent BioSolutions News Today Sage Therapeutics News Today FibroGen News Today Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today BeiGene News Today United Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
